MBC BioLabs Announces New Partnership with Refeyn

[San Francisco, CA – July 14, 2025] – MBC BioLabs is proud to announce it has entered into a partnership with Refeyn. This partnership will help support the mission of enabling awesome for MBC BioLabs’ community of high-growth biotech start-up companies.

About Refeyn
Refeyn, the pioneer of mass photometry, is delivering a disruptive new generation of analytical instruments that let you weigh individual molecules with light. Mass photometry offers new possibilities to characterise the function, structural composition and dynamics of biomolecules. Refeyn instruments measure the mass of individual molecules directly in solution, rapidly, and simply, revealing the true behaviour of molecules in near-native environments, providing scientists with key information about their mass distribution.

Refeyn was spun out of Oxford University in 2018 to make mass photometry available globally. Its technology has now been rapidly adopted across academia and industry, where it is transforming biomolecular characterisation.

For more information, please visit our official website at www.refeyn.com or follow us on LinkedIn by searching for “Refeyn”.

About MBC BioLabs
At MBC BioLabs, we believe that startups are the greatest force for positive change in the world. We are dedicated to helping biotech startups succeed – we like to say that we enable awesome. We offer flexible and cost-effective lab space, complete with operational support and millions of dollars’ worth of state-of-the-art equipment and instrumentation, along with a vibrant community of like-minded individuals tackling the world’s biggest problems.

We have helped launch and grow over 400 companies since opening in October of 2013, and together, MBC companies have initiated 176 clinical trials, introduced 135 products to market, and collectively raised over $20 billion. Learn more at mbcbiolabs.com.